CELLTRION

celltrion-logo

Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.

#SimilarOrganizations #People #Financial #Website #More

CELLTRION

Social Links:

Industry:
Biotechnology Health Care Manufacturing

Founded:
2002-02-01

Address:
Incheon, Inch'on-jikhalsi, South Korea

Country:
South Korea

Website Url:
http://www.celltrion.com

Total Employee:
1001+

Status:
Active

Contact:
+82328505000

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag


Similar Organizations

albatha-logo

Albatha

Albatha is an investment holding with investments & development in the automotive, healthcare, manufacturing, food, & electronics sectors.

atrium-medical-logo

Atrium Medical

Atrium Medical Corporation, a healthcare company, engages in the research and development, design, and manufacture of medical device

beike-biotechnology-logo

Beike Biotechnology

Beike is the stem cell provider focusing on the research, development, and clinical translation of adult stem cells.

ck-life-sciences-international-logo

CK Life Sciences International

CK Life Sciences International is engaged in the business of research and development, manufacturing, commercialisation, marketing, sale of.

gaba-international-logo

GABA International

GABA International is engaged in the research, development, manufacture, and marketing of oral care products.

jianlaifu-logo

Jianlaifu

Jianlaifu engages in health food research and development, contract manufacturing, and sales operations.

naturalendo-tech-logo

Naturalendo Tech

Naturalendo Tech is engaged in the research and development and manufacture of hormone products

pharming-group-logo

Pharming Group

Pharming Group is a developer and manufacturer of human therapeutic proteins.

polymate-logo

Polymate

Polymate Ltd is a research facility that develops hybrid polyurethane materials and fire protective coatings.

reprocell-logo

ReproCELL

ReproCELL Incorporated is primarily engaged in the development of stem cell technologies.

sanofi-logo

Sanofi

Sanofi is engaged in the research, development, manufacturing, and marketing of innovative therapeutic solutions.

sinocare-logo

Sinocare

Sinocare Inc. has been dedicating itself to bio-sensor technology research & development, manufacturing and marketing.

t-mab-biopharma-logo

T-mab BioPharma

T-mab BioPharma is specializing in the research and development and production of genetically engineered drugs

yunnan-botanee-bio-technology-group-logo

Yunnan Botanee Bio Technology Group

Yunnan Bethany Biotechnology manufactures and markets skin care products.

Current Employees Featured

seungsuh-hong_image

SeungSuh Hong
SeungSuh Hong SVP, Business Development @ Celltrion
SVP, Business Development

not_available_image

Jung Jin Seo
Jung Jin Seo Founder @ Celltrion
Founder

Founder


not_available_image

Jung Jin Seo

Stock Details


Company's stock symbol is KOSDAQ:068270

Investments List

Date Company Article Money raised
2021-06-07 Iksuda Therapeutics Celltrion investment in Series A - Iksuda Therapeutics 47 M USD

Official Site Inspections

http://www.celltrion.com Semrush global rank: 1.07 M Semrush visits lastest month: 31.23 K

  • Host name: 13.107.253.40
  • IP address: 13.107.253.40
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Celltrion"

Celltrion

Celltrion maintains a high production success rate of over 99% through continuous improvement of quality control policies leading to a long-term record of contamination- and accident-free โ€ฆSee details»

CelltrionUSA

About Celltrion USA Established in 2018, Celltrion USA, headquartered in Jersey City, is committed to expanding patient access to high quality biopharmaceuiticals. Celltrion USA will continue to leverage Celltrion's unique โ€ฆSee details»

Celltrion - Wikipedia

Celltrion, Inc. (Korean: ์ฃผ์‹ํšŒ์‚ฌ ์…€ํŠธ๋ฆฌ์˜จ) is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Yโ€ฆSee details»

Celltrion Healthcare

Celltrion Healthcare will shape a healthier and happier future for humanity by offering high-quality biologics. Celltrion Healthcare offers biologics to about 110 countries, along with more than 30 global partners around the world. With โ€ฆSee details»

Celltrion Healthcare Co.,Ltd. - Org Chart, Teams, Culture & Jobs

Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines through an extensive global network that spans more than 110 different countries. Celltrion โ€ฆSee details»

Celltrion

Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 (biosimilar candidate of denosumab) and CT-P47 (biosimilar candidate of tocilizumab) at ACR Convergence 2024 ...See details»

Celltrion

The cornerstone of Celltrion's global biotechnology leadership is its Global R&D Center, where cutting-edge biosimilars and novel drug modalities are brought to life. Leveraging a wealth of experience in global clinical trials and mAb โ€ฆSee details»

Celltrion - Crunchbase Company Profile & Funding

Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, โ€ฆSee details»

Celltrion | European Clinical Trials Information Network

Celltrion has a strong track record of success in the biosimilars market, having developed and commercialized several biosimilars that have been approved by regulatory agencies around โ€ฆSee details»

Celltrion to break ground on CDMO plant in 2025: Chairman Seo

Nov 28, 2024 South Koreaโ€™s leading biosimilar developer Celltrion Inc. will break ground on its first contract development and manufacturing organization (CDMO) plant in Korea next year, โ€ฆSee details»

Celltrion Healthcare - Crunchbase Company Profile & Funding

Celltrion Healthcare is committed to delivering innovative and affordable medications to promote patientsโ€™ access to advanced therapies. Access to advanced yet costly therapeutics is often a โ€ฆSee details»

Celltrion Company Profile 2024: Stock Performance & Earnings

Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, โ€ฆSee details»

Celltrion

©Celltrion USA, Inc. โ€ข 1 Evertrust Plaza, Suite 1207, Jersey City, NJ 07302-3087. Contact us at 877-81CONNC (877-812-6662) ...See details»

Celltrion Inc. Information - RocketReach

The NAICS codes for Celltrion Inc. are [32541, 325414, 32, 3254, 325]. What is the SIC code for Celltrion Inc.? The SIC codes for Celltrion Inc. are [283, 28]. Top Celltrion Inc. Employees Seo โ€ฆSee details»

Celltrion Healthcare

Celltrion is a combination of the terms โ€œcellโ€ in our body and โ€œTriones,โ€ a guiding star that is also known as the Big Dipper. The name of our company conveys our will to promote the health โ€ฆSee details»

Celltrion

Jan 11, 2024 Celltrion pursues sustainable growth by leveraging its experience and assets in the successful biosimilar business to develop new medicines and healthcare platform โ€ฆSee details»

Celltrion - Overview, News & Similar companies | ZoomInfo.com

Celltrion strives to provide more affordable biosimilar mAbs to patients who previously had limited access to advanced therapeutics. Celltrion received FDA and EC's approval for Inflectra® and โ€ฆSee details»

Celltrion CONNECT โ€“ Caring for you every step of the way.

The Celltrion CONNECT® Patient Support Program provides ongoing support to patients prescribed a Celltrion medication. Please select which support resources you want to explore: โ€ฆSee details»

Celltrion

Nov 16, 2024 As announced on September 9, Celltrion has set revenue targets of 3.5 trillion KRW for 2024 and 5 trillion KRW for 2025. ... (Contract Development and Manufacturing โ€ฆSee details»

Celltrion Online Brochure

Celltrion is a leading global biopharmaceutical company that researches, develops and manufactures antibody biosimilars, new biologics and small molecule drugs. We have โ€ฆSee details»

linkstock.net © 2022. All rights reserved